VITROS ECI IMMUNODIAGNOSTIC ANALYZER - CLASS II 의 리콜

Health Canada (via FOI)에 따르면, 해당 리콜 는 Canada 에서 ORTHO-CLINICAL DIAGNOSTICS 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    80204
  • 사례 위험등급
    II
  • 사례 시작날짜
    2011-08-29
  • 사례 국가
  • 사례 출처
    HC
  • 비고 / 경고
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • 데이터 추가 비고
  • 원인
    There is a software issue that may affect results from diluted samples run on the vitros eci immunodiagnostic system tested with the vitros immunodiagnostics products total beta-hcg ii reagent pack. ocd has received complaints of observed results from diluted samples that were reported as <2.39 miu/ml (iu/l) instead of the correct 'no result' which is accompanied by an invalid dilution (id) code. the diluted results were inconsistent with results from the neat (undiluted) sample which was within the measuring range of 2.39-15000 miu/ml.

Device

  • 모델명 / 제조번호(시리얼번호)
    Model Catalog: 863 3893 (Lot serial: Lots 0484 and above); Model Catalog: 1922814 (Lot serial: Lots 0484 and above)
  • 제품 설명
    VITROS ECi/ECiQ Immunodiagnostic Systems Software V 3.8 & below/VITROS Immunodiagnostic Products Total beta-hCG II Reagent Packs Lots 0484 & Above
  • Manufacturer

Manufacturer